- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04284605
Effects Exercise Training in Patients With Pituitary Adenoma
Effects of Aerobic Training Combined With Strength Training and Yoga on Biochemical Factors, Physical Performance and Quality of Life in Patients With Pituitary Adenoma
This study planned to investigate the effects of aerobic training combined with strengthening training and yoga on biochemical factors, physical performance and quality of life in people with pituitary adenoma. The hypotheses are; H1: Aerobic training combined with strengthening training is effective on biochemical factors in people with pituitary adenoma.
H2: Aerobic training combined with strengthening training is effective on physical performance in people with pituitary adenoma.
H3: Aerobic training combined with strengthening training is effective on quality of life in people with pituitary adenoma.
H4: Yoga is effective on biochemical factors in people with pituitary adenoma. H5: Yoga is effective on physical performance in people with pituitary adenoma. H6: Yoga is effective on quality of life in people with pituitary adenoma. H7: Aerobic training combined with strengthening training and yoga is effective on biochemical factors, physical performance and quality of life in people with pituitary adenoma.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Çankaya
-
Ankara, Çankaya, Turkey, 06530
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- volunteers
- macroadenomas
- at least 1 hormonal axis affected
- Karnofsky Perfomance Scale between 70-100
- 18-65 years
- approved by cardiologists
Exclusion Criteria:
- regular exercise habit
- acute pain in many part of the body
- additional neurologic condititons
- any rheumatological and immunologic conditions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group1
|
30 minute aerobic exercise training with warm-up and cool down followed by 30 minute strength training for specific muscles.
60 minute yoga intervention including different asanas, breath control and meditation
|
Experimental: Group2
|
30 minute aerobic exercise training with warm-up and cool down followed by 30 minute strength training for specific muscles.
60 minute yoga intervention including different asanas, breath control and meditation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biochemical Factors
Time Frame: 6 weeks
|
Concentrations of IL6, IL1beta, TNFalfa in serum
|
6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Endocrine System Diseases
- Endocrine Gland Neoplasms
- Hypothalamic Diseases
- Hypothalamic Neoplasms
- Supratentorial Neoplasms
- Brain Neoplasms
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Adenoma
- Pituitary Neoplasms
- Pituitary Diseases
Other Study ID Numbers
- KA-180156
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pituitary Adenoma
-
Asan Medical CenterUnknownPituitary ACTH Secreting AdenomaKorea, Republic of
-
Zhaoyun ZhangUnknownPituitary TumorChina
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
University of CopenhagenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedAcromegaly Due to Pituitary AdenomaDenmark
-
Samsung Medical CenterNot yet recruitingAcromegaly Due to Pituitary AdenomaKorea, Republic of
-
Vastra Gotaland RegionRecruitingNon-functioning Pituitary AdenomaSweden
-
Asan Medical CenterUnknownCavernous Sinus Invasion by Pituitary AdenomaKorea, Republic of
-
Zealand University HospitalNot yet recruitingNon-Functional Pituitary Adenoma
-
Novartis PharmaceuticalsCompleted
-
University of Sao Paulo General HospitalCompletedPituitary Adenoma | Nonfunctioning Pituitary AdenomaBrazil
Clinical Trials on Aerobic exercise combined with strength training
-
Wonju Severance Christian HospitalRecruitingBreast CancerKorea, Republic of
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
University of LisbonCompletedChronic Heart Failure | FragilityPortugal
-
Wan-Yun HuangKaohsiung Veterans General Hospital.; National Cheng Kung UniversityCompletedVirtual Reality | Physical FitnessTaiwan
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Amsterdam UMC, location VUmcAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)CompletedType 2 Diabetes Mellitus | Insulin Sensitivity/ResistanceNetherlands
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)CompletedDiabetic | CardiovascularCanada
-
Norwegian University of Science and TechnologyCompleted
-
Baltimore VA Medical CenterUniversity of Maryland, BaltimoreActive, not recruiting